| Krystle Aguirre Leacock, MD | |
|
1500 Forest Glen Rd, Silver Spring, MD 20910-1460 | |
| (301) 942-8799 | |
| Not Available |
| Full Name | Krystle Aguirre Leacock |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 1500 Forest Glen Rd, Silver Spring, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568728533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D0081928 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Montgomery Medical Center | Olney, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
News Archive
In experiments with isolated cystic fibrosis lung cells, University of Alabama at Birmingham researchers and colleagues from two other institutions have partially restored the lost function of those cells.
According to Dr Tony Calland, the British Medical Association's (BMA) chairman in Wales, the Welsh Assembly Government's understanding of the NHS is better under Health Minister Dr Brian Gibbons.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research.
› Verified 6 days ago
| Entity Name | Holy Cross Anesthesiology Associate, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376501007 PECOS PAC ID: 3577454313 Enrollment ID: O20040322001776 |
News Archive
In experiments with isolated cystic fibrosis lung cells, University of Alabama at Birmingham researchers and colleagues from two other institutions have partially restored the lost function of those cells.
According to Dr Tony Calland, the British Medical Association's (BMA) chairman in Wales, the Welsh Assembly Government's understanding of the NHS is better under Health Minister Dr Brian Gibbons.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research.
› Verified 6 days ago
| Entity Name | Comfort Sedation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609805407 PECOS PAC ID: 2567464423 Enrollment ID: O20070206000044 |
News Archive
In experiments with isolated cystic fibrosis lung cells, University of Alabama at Birmingham researchers and colleagues from two other institutions have partially restored the lost function of those cells.
According to Dr Tony Calland, the British Medical Association's (BMA) chairman in Wales, the Welsh Assembly Government's understanding of the NHS is better under Health Minister Dr Brian Gibbons.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research.
› Verified 6 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171129001837 |
News Archive
In experiments with isolated cystic fibrosis lung cells, University of Alabama at Birmingham researchers and colleagues from two other institutions have partially restored the lost function of those cells.
According to Dr Tony Calland, the British Medical Association's (BMA) chairman in Wales, the Welsh Assembly Government's understanding of the NHS is better under Health Minister Dr Brian Gibbons.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research.
› Verified 6 days ago
| Entity Name | Anesthesia Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871548156 PECOS PAC ID: 4587559026 Enrollment ID: O20180522001908 |
News Archive
In experiments with isolated cystic fibrosis lung cells, University of Alabama at Birmingham researchers and colleagues from two other institutions have partially restored the lost function of those cells.
According to Dr Tony Calland, the British Medical Association's (BMA) chairman in Wales, the Welsh Assembly Government's understanding of the NHS is better under Health Minister Dr Brian Gibbons.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Krystle Aguirre Leacock, MD 2730 University Blvd W, West Suite 104, Wheaton, MD 20902-1905 Ph: (304) 237-4987 | Krystle Aguirre Leacock, MD 1500 Forest Glen Rd, Silver Spring, MD 20910-1460 Ph: (301) 942-8799 |
News Archive
In experiments with isolated cystic fibrosis lung cells, University of Alabama at Birmingham researchers and colleagues from two other institutions have partially restored the lost function of those cells.
According to Dr Tony Calland, the British Medical Association's (BMA) chairman in Wales, the Welsh Assembly Government's understanding of the NHS is better under Health Minister Dr Brian Gibbons.
Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.
American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research.
› Verified 6 days ago
Dr. Johannes Craig Kutten, MD, PHD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 301-754-7000 | |
Dr. Vincent J Vilasi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 703-980-4187 | |
Zubair K Niazi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Forest Glen Rd Ste 120, Silver Spring, MD 20910 Phone: 410-274-6534 | |
Tzvi Grossman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1106 Arcola Ave, Silver Spring, MD 20902 Phone: 800-533-3669 | |
Dr. Anthony Rossi, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11890 Healing Way, Silver Spring, MD 20904 Phone: 240-637-4000 | |
Barbara Fern Goldschlag, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12018 Auth Ln, Silver Spring, MD 20902 Phone: 301-742-8989 | |
Eric Adam Zelman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 301-754-7000 |